Electromagnetic Field Treatment for Ischemic Stroke Neuroprotection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for cerebral ischemic stroke, such as thrombolysis through tissue plasminogen activator (rt-PA), are limited in effectiveness and accessibility, failing to adequately address neuronal degeneration and recovery in a significant portion of stroke patients, particularly those with varying brain damage locations and extents.

Innovation Solution

A method involving the application of a targeted electromagnetic field, specifically within the range of 1 to 3 mTesla, to reduce local edema and neuronal apoptosis in the ischemic area, using a headset with a solenoid and software to identify and treat the affected brain region, thereby promoting neuronal survival and recovery.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If thrombolysis through rt-PA is used to treat ischemic stroke, then perfusion in the ischemic penumbra is partially restored, but the treatment is limited to cases reaching specialized hospitals within a few hours and excludes patients with bleeding disorders

Engineering Contradiction:
Improveeffectiveness of stroke treatmentVSAvoidapplicability to different patient groups
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent replaces the pharmacological mechanism of rt-PA (chemical thrombolysis) with an electromagnetic field-based mechanical/physical intervention. The electromagnetic field acts directly on the ischemic tissue to modulate cellular processes, reduce edema, and prevent neuronal death without relying on chemical breakdown of clots, thereby expanding treatment eligibility beyond the narrow window and contraindications of rt-PA

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the fundamental treatment parameter from chemical pharmacology (rt-PA dosage and timing) to physical electromagnetic field parameters (frequency, intensity, duration). This parameter shift enables treatment of patients who cannot receive rt-PA due to timing constraints or bleeding risks, as the electromagnetic field mechanism does not depend on the same pharmacokinetic and contraindication constraints

Inventive Principle:
Principle #35Parameter changes

2Reliability

If rt-PA is administered to restore perfusion in the ischemic penumbra, then further damage to this area is prevented, but the central ischemic core necrosis remains irreversible and cerebral edema develops

Engineering Contradiction:
Improveprotection of ischemic penumbraVSAvoidcerebral edema from necrotic tissue
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The electromagnetic field treatment applies preliminary protective effects to both the penumbra and the ischemic core before irreversible necrosis and edema fully develop. By acting early on the ischemic tissue, the field prevents the cascade of cellular death and subsequent edema formation that would otherwise occur in the core, while simultaneously protecting the penumbra

Inventive Principle:
Principle #9Preliminary anti-action

Solution Approach 2:

The patent converts the previously harmful electromagnetic exposure into a beneficial therapeutic intervention. By applying controlled electromagnetic fields with specific parameters, the treatment transforms potential cellular stress into protective effects, reducing edema and promoting neuronal survival in both the penumbra and core regions

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

3Reliability

If a standardized electromagnetic field device is used for cartilage treatment, then cartilaginous tissue integrity is preserved, but the device cannot target specific injured areas at different depths or sizes

Engineering Contradiction:
Improvetissue integrity preservationVSAvoidtargeting capability for different injury locations
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent transforms the static, standardized electromagnetic field device into a dynamic system that can adapt to different treatment needs. The device adjusts electromagnetic field parameters (frequency, intensity, duration, focal point) in real-time based on the specific characteristics of the ischemic stroke case, enabling precise targeting of different brain regions at varying depths while maintaining tissue integrity

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The patent applies the principle of local quality by delivering electromagnetic field energy with spatial precision to the specific ischemic brain region rather than uniformly treating the entire head. The field parameters are optimized for the local tissue characteristics and injury severity at the target site, enabling differentiated treatment of various brain areas

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The electromagnetic field treatment has shown significant reduction in ischemic area size, increased neuronal survival, and improved recovery in preclinical trials, with potential for safer and more effective neuroprotection compared to pharmacological therapies.

Implementation Method 1

applying an effective electromagnetic field to the ischemic area of the brain... the electromagnetic field is effective to reduce local edema, to increase neuronal survival and/or to reduce neuronal apoptosis

Methodology Applied
Scientific EffectElectromagnetic field: Electromagnetic Induction

Data Source

PatentUS10376707B2Method for the treatment of ischemic stroke by applying an electromagnetic field
Publication Date: 2019.08.13 IGEA SPA
  • US10376707B2 patent drawing
  • US10376707B2 patent drawing
  • US10376707B2 patent drawing

AI summary

There is disclosed a method for the treatment of cerebral ischemic stroke in a subject in need thereof comprising the steps of (a) identifying an ischemic area of the brain of the subject; and (b) applying an effective electromagnetic field to the ischemic area of the brain, wherein the electromagnetic field is effective to reduce local edema, to increase neuronal survival and/or reduce neuronal apoptosis.